戻る Agenda
Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance
Session Chair(s)
Lisa Wittmer, PhD
President
Theorogen Consulting, United States
Antimicrobial resistance (AMR) is a threat to global health. Reactive efforts to address AMR risks lives, economies, and security. A proactive preparedness model relies on innovation in development and regulatory pathways.
Learning Objective : Review the current regulatory framework in the context of increasing AMR; Discuss regulator’s role in ensuring development feasibility; Identify areas for improvement.
Speaker(s)
Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance
Sumathi Nambiar, MD, MPH
Johnson & Johnson, United States
Senior Director, Child Health and Innovation Leadership Department
EMA Update
Marco Cavaleri, PhD
European Medicines Agency, Netherlands
Head of Health Threats and Vaccines Strategy
Panelist
Paul Christopher McGovern
Venatorx Pharmaceuticals, Inc., United States
Vice President, Medical Sciences